BHVN
Biohaven Ltd.
Company Overview
| Mkt Cap | $1.51B | Price | $17.20 |
| Volume | 2.43M | Change | -1.09% |
| P/E Ratio | -1.8 | Open | $17.20 |
| Revenue | -- | Prev Close | $17.39 |
| Net Income | $-846.4M | 52W Range | $12.79 - $54.98 |
| Div Yield | N/A | Target | $44.63 |
| Overall | 51 | Value | 40 |
| Quality | 31 | Technical | 83 |
No chart data available
Stock Overview
Updated DailyBiohaven Ltd. (BHVN) is a leading Healthcare company in the Biotechnology industry, currently trading at $17.20 with a market capitalization of $1.51 billion. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating concerning quality fundamentals with a MarketXLS quality score of 31.
Today's trading session shows BHVN with a volume of 2.43 million shares. The stock opened down 1.09% from yesterday's close of $17.39. Current analyst estimates project earnings of $-7.73 per share for this year, with next year targeting $-5.83.
BHVN demonstrates very strong technical momentum based on technical analysis. The company trades on the NYE exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for BHVN include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 159.5%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 07:11 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BHVN | $17.20 | -1.1% | 2.43M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |